A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension. (2019)

First Author: Arnold N

Attributed to: Investigation of MiR-140-5p in Humans and Experimental Models of Pulmonary Arterial Hypertension. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.47073

Publication URI: https://www.repository.cam.ac.uk/handle/1810/300001

Type: Other